Previous research has observed that individuals with chronic pain demonstrate slower alpha band 27 oscillations (8-12 Hz range) during resting electroencephalography (EEG) than do age-matched, healthy 28 controls. While this slowing may reflect pathological changes within the brain that occur during the 29 chronification of pain, an alternative explanation is that healthy individuals with slower alpha 30 frequencies are more sensitive to prolonged pain, and by extension, more susceptible to developing 31 chronic pain. To formally test this hypothesis, we examined the relationship between the pain-free, 32 resting alpha frequency of healthy individuals and their subsequent sensitivity to two experimental 33 models of prolonged pain, Phasic Heat Pain and Capsaicin Heat Pain, at two testing visits separated by 8 34 weeks on average (n = 61 Visit 1, n = 46 Visit 2). We observed that the speed of an individual's pain-free 35 alpha oscillations was negatively correlated with sensitivity to both prolonged pain tests and that this 36 relationship was reliable across short (minutes) and long (weeks) timescales. Furthermore, we used the 37 speed of pain-free alpha oscillations to successfully identify those individuals most sensitive to 38 prolonged pain, which we also validated on data from a separate, independent study. These results 39 suggest that alpha oscillation speed is a reliable biomarker of prolonged pain sensitivity with the 40 potential to become a tool for prospectively identifying pain sensitivity in the clinic. 41
Introduction 42
Chronic pain is a debilitating condition with cognitive, affective, and sensory symptoms that afflicts 43 nearly one fifth of the American population (Kennedy et al., 2014) , leading to treatment and work loss 44 costs totaling nearly six hundred billion dollars annually (Gaskin & Richard, 2012) . Identifying individuals 45 at high risk for developing chronic pain is a crucial, but under-explored, avenue for combatting chronic 46 pain and its related economic burdens. At present, prediction of chronic pain development is poor: for 47 example, one of the best predictors of persistent post-surgical pain is the intensity of pain reported 48 directly after surgery (e.g Katz et al., 1996) . While useful for post-operative case management, these 49
measures cannot be used to identify, and target prophylactic treatments to, individuals at risk for 50 developing chronic pain. What is urgently needed is a measure of an individual's sensitivity to prolonged 51 pain that can be obtained prior to medical intervention. To that end, the objective of the current study 52 is to systematically investigate the hypothesis that an individual's peak alpha frequency, measured with 53 resting state electroencephalography (EEG), is a trait-like marker of their sensitivity to prolonged pain. 54
The alpha rhythm (8-12 Hz) is the predominant oscillatory activity observed in scalp-recorded EEG of the 55 primary sensory cortices (e.g. occipital, somatosensory) while an individual is quietly resting. Across 56 individuals, there is considerable variability in the alpha band frequency from which the greatest power 57 is recorded (Haegens et al, 2014 , Bazanova & Vernon, 2014 . This frequency, often labeled the Peak or 58
Individual Alpha Frequency (PAF/IAF), has been suggested to contribute to individual differences in 59 multiple psychological and physiological processes (e.g. Klimesch been interpreted to reflect pathological changes within the brain that occur during the chronification of 65 pain (Llinás et al., 1999) . Work from our lab has, however, shown that slow PAF, recorded in the absence 66 of pain (i.e. pain-free PAF), also reflects heightened sensitivity to prolonged pain in healthy individuals 67 (Furman et al, & 2019 . Given that heightened pain sensitivity is a risk factor for developing chronic 68 pain (Diatchenko et al., 2005) , an alternative interpretation of the aforementioned chronic pain findings 69 is that slow PAF reflects an increased sensitivity to prolonged pain that predates disease onset. Put 70
another way, slow PAF may reflect a predisposition for developing chronic pain rather than a result of its 71 development. 72
In the current study, we sought to further characterize the relationship of pain-free PAF to prolonged 73 pain sensitivity by exposing participants to two experimental models of prolonged pain, Phasic Heat Pain 74 (PHP) and Capsaicin Heat Pain (CHP), at two testing visits separated by multiple weeks. This study design 75 allowed us to test two key predictions of the hypothesis that pain-free PAF is a trait-like marker of an 76 individual's sensitivity to prolonged pain: (1) that pain-free PAF reflects pain sensitivity to multiple 77 prolonged pain tests; and (2) that an individual's pain-free PAF can predict their sensitivity to prolonged 78 pain at more than one point in time. In addition to these main aims, and with an eye towards its 79 potential clinical application, we also examined whether pain-free PAF can be used to successfully 80 identify high and low pain sensitive individuals. 81
Materials and methods 82
Participants 83
Sixty-one pain-free, neurotypical adult participants (31 males, mean age = 27.82, age range = 21-42) 84 took part in the experiment between 7/6/2016 and 10/20/2017. This study was approved by the 85 University of Maryland, Baltimore Institutional Review Board, and informed written consent was 86 obtained from each participant prior to any study procedures. The study was pre-registered on 87
ClinicalTrials.gov (NCT02796625). 88 Table 1 provides information regarding how many participants contributed data to each analysis. 89
Scalp EEG was collected from an EEG cap housing a 63 channel BrainVision actiCAP system (Brain 91
Products GmbH, Munich, Germany) labeled according to an extended international 10-20 system 92 (Oostenveld and Praamstra, 2001 ). All electrodes were referenced online to the average across all 93 recording channels and a common ground set at the AFz site. Electrode impendences were maintained 94 below 5 kΩ throughout the experiment. Brain activity was continuously recorded within a 0.01-100 Hz 95 bandpass filter, and with a digital sampling rate of 500 Hz. The EEG signal was amplified and digitized 96 using an actiCHamp DC amplifier (Brain Products GmbH, Munich, Germany) linked to BrainVision 97
Recorder software (version 2.1, Brain Products GmbH, Munich, Germany). 98
Thermal Stimulator and Pain Scale 99
Thermal stimuli were delivered to the volar surface of the participant's left forearm using a thermal 100 contact heat stimulator (27mm diameter Medoc Pathway CHEPS Peltier device; Medoc Advanced 101 Medical Systems Ltd., Ramat Yishai, Israel). 102
Unless otherwise stated, pain ratings were collected continuously with a manual analog scale consisting 103 of a physical sliding tab (Medoc Advanced Medical Systems Ltd., Ramat Yishai, Israel). Prior to testing, 104 participants were instructed that the lower and upper bounds of the scale represented no pain and the 105 most pain imaginable, respectively, and that they should continuously update the position slider to 106 indicate the amount of pain currently being experienced. Care was taken by experimenters to avoid 107 providing numerical anchors when describing the scale and no additional physical landmarks were 108 present on the scale. Prior to testing, participants were given an opportunity to practice using the device 109
with their eyes open and closed. During testing, participants were permitted to briefly open their eyes 110 while rating. 111
Pain ratings were collected from the manual analog scale at a rate of 1000 Hz. Manual analog scale data 112 was transformed by converting the horizontal position of the slider into a continuous value between 0 113 and 100. 114
Quantitative Sensory Testing 115
Participants were asked to complete four threshold tests: 1) to report when they felt a temperature 116 increase (Warmth Detection Threshold); (2) to report when they felt a temperature decrease (Cool 117 Detection Threshold); (3) to report when an increasing temperature first became painful (Heat Pain 118 Threshold); and (4) to report when a decreasing temperature first became painful (Cold Pain Threshold).
119
A total of three trials were presented for each test with an ISI of 4-6 seconds (randomly determined on a 120 per trial basis). Participants provided feedback for each test by clicking either the left or right button of a 121 computer mouse placed in their right hand. For each test, temperatures were applied with a rise rate of 122 1°C/second and return rate of 2°C/second (initiated on any mouse click). 123
All testing was performed on the volar surface of the left forearm. The distance from the wrist to elbow 124 joint was measured and the forearm was divided into three equal length zones. For each test, the first 125 trial was administered to the zone closest to the wrist, the second trial administered to the middle 126 forearm zone, and the third trial administered to the zone closest to the elbow. 127
Phasic Heat Pain (PHP) Model 128
Temperatures used during the PHP model were determined during each participant's initial screening 129 visit to the laboratory (Visit 0). During these sessions, participants were exposed to 12, 20 second trials 130 in which a single temperature (2.5 second rise and fall) was applied to the volar surface of the left 131 forearm. At the conclusion of each trial, participants reported the average pain they experienced during 132 temperature application; participants were instructed to report pain ratings on a scale of 0-10, with 0 133 indicating no pain and 10 the most pain imaginable. Temperatures ranged from 37 to 48°C (intervals of 134 2°C, starting as if 37°C was 38°C) and each temperature was presented twice in a pseudorandom order. 135
Trials were separated by 10 seconds and after each trial the thermode was moved to a neighboring 136 forearm zone in order to minimize sensitization. Using pain reports from these trials, the temperature 137 that most closely evoked an average pain rating of 5/10 was selected. This level of pain was targeted in 138 order to best match the intensity of pain evoked by the CHP model . For a few 139 participants, none of temperatures were able to evoke a 5/10 pain rating. For these individuals, 48°C 140 was used during PHP testing. 141 Figure 1 . Outline of the experimental procedure. After a brief sensory testing session, participants completed a pain-free EEG. Next, participants completed a "Phasic Heat Pain (PHP)" EEG. After a 5-minute period in which an ice pack was applied to the skin, a second pain-free EEG was collected (not shown). Afterwards, capsaicin was applied to the forearm and incubated for twenty minutes. Next, a "Capsaicin-Heat Pain (CHP)" EEG was completed while a 40°C thermode was placed on top of the capsaicin. After a 5-minute period in which an ice pack was applied to the skin and a third pain-free EEG was collected (not shown), the 40°C thermode was again placed on top of the capsaicin and a 5-minute eyesclosed "CHP rekindle" EEG was completed. For each EEG, data was collected for 5 minutes while participants were instructed to keep their eyes closed. Identical procedures were performed at Visit 1 and Visit 2. To further test of the reliability of CHP sensitivity, we included a "rekindling" phase (CHP rekindle; Dirks 161 et al., 2003) . After the initial CHP testing was completed, an icepack (see below for details) was applied 162 to the forearm until a complete termination of pain was reported. Afterwards, the thermode was again 163 placed over top of the site of capsaicin application, heated to 40°C, and held in place for five minutes. 164 CHP rekindle scores were calculated as the average of the pain ratings provided during this five-minute 165 period. 166
Icepack Application 167
At the conclusion of the PHP and CHP tests, the thermode was removed and a disposable icepack was 168 applied the stimulated area of the left forearm. This was done to prevent pain carryover from one test 169 to another and to ensure that pain ratings for subsequent tests were captured from a starting state of 170 no ongoing pain. The icepack was left in place until the complete absence of pain was reported by the 171 participant. No participants indicated that the icepack itself was ever painful. Following each icepack 172 application, a 5-minute pain-free, eyes closed EEG session occurred. 173
Procedure 174
An outline of the experimental timeline and procedures is presented in Figure 1 . In order to allow 175 sufficient time for any long-term effects of capsaicin exposure to subside, visits were separated by 21 176 recorded while participants continuously rated the intensity of any perceived pain. 207
Data Processing 208
Because our primary objective was predicting pain sensitivity, the EEG data of interest were the initial 209 pain-free EEGs collected at the beginnings of Visits 1 and 2. EEG data were preprocessed with EEGLAB 210 13.6.5b (Delorme and Makeig, 2004) . Preprocessing began with filtering the data between .2 and 100Hz 211 using a linear FIR filter. Channel data were then visually inspected and overtly noisy channels were 212 removed from further analysis. Removed channels were not interpolated. On average, 1.64 (S.D. = 1.92, 213 range: 0 -8) and 1.79 (S.D. = 1.79, range: 0 -6) channels were removed per individual from Visit 1 and 214
Visit 2 datasets, respectively. Finally, Principal Components Analysis (PCA) was performed and 215 components with spatial topographies and time series resembling blinks and/or saccades were removed 216 from the data. 217
As opposed to our previous studies which used ICA to isolate alpha sources over visual and 218 somatosensory regions, we used channel level data to increase the ease with which our methods can be 219 reproduced. Although it may decrease the signal to noise ratio of the data, this approach eliminates the 220 need to identify ICA components on a participant by participant basis and is equally effective for 221 capturing the PAF-pain sensitivity relationship (Furman et al., 2019 ). For channel level analyses, we 222 focused on channels (C3, Cz, and C4) that most strongly reflected the sensorimotor component 223 topography observed in our original study . If a channel from this sensorimotor 224 region of interest (ROI) was removed due to noise, only the remaining channels were used; this affected 225 few participants (Visit 1: n = 4; Visit 2: n = 1) and no participant had more than one channel removed. In 226 order to make the current results easily comparable to previous findings, all main analyses use PAF 227 calculated from this sensorimotor ROI; use of this ROI is not intended to imply a mechanism or source 228 for any documented effects. 229
To explore if additional EEG channels capture the PAF-pain sensitivity relationship, the surface Laplacian 230 was computed following preprocessing (Perrin et al., 1989) . Results from analyses using this estimate of 231 current source density can be found in the Supplemental Data ( Figure S6 ). 232
Quantification of Sensorimotor PAF 233
The frequency decomposition of the sensorimotor ROI data was performed using routines in FieldTrip 234 (Oostenveld et al., 2011) . Data from each pain-free EEG session was segmented into non-overlapping 5 235 second epochs and power spectral density in the .2-100 Hz range (0.2 Hz bins) was derived with the 236 'ft_freqanalysis_mtmfft' function. A Hanning taper was applied to the data prior to calculating the 237 spectra to reduce edge artifacts (e.g. Mazaheri et al., 2014) . 238
At every channel and for each epoch, PAF was estimated using a center of gravity (CoG) method 239 (Klimesch et al., 1993) . We defined CoG as follows: 240 241 where fi is the ith frequency bin including and above 9 Hz, n is the number of frequency bins between 9 242 and 11 Hz, and ai the spectral amplitude for fi. From our previous work, we have determined that this 243 restricted frequency range reduces the influence of 1/f EEG noise on PAF estimation (Furman et al., 244 2018) . Epoch-level PAF estimates were averaged to yield a single mean PAF estimate for each channel. 245
Channel-level PAF estimates were further averaged across sensorimotor channels to yield a single 246 sensorimotor PAF estimate for each participant at each visit. 247
To ensure that results were not an artifact of the range used for PAF estimation, PAF was additionally 248 calculated with the wider 8-12 Hz range. Results with this wider estimation range are presented 249
throughout the text and PAF estimates calculated using either the 9-11 or 8-12 ranges were highly 250 similar ( Figure S2 ). 251
Statistical Analysis 252
All analyses were performed using custom scripts implemented in the Matlab environment (version 253 R2013A Next, we determined whether pain-free, sensorimotor PAF can accurately identify the most or least pain 284 sensitive individuals. In the first analysis, we used a series of linear support vector machines (SVM) to 285 perform leave-one-out, within-study classification (internal validation). To do so, pain scores from PHP, 286 CHP, and CHP rekindle were averaged and, in separate tests, the top or bottom 10% of averaged pain 287 scores were labelled as targets. A series of SVMs were then trained to identify targets based on Visit 1 288 baseline, pain-free PAF estimates from all but one individual (training set). Trained support vector 289 machines were then used to predict whether the withheld participant was a target. Visit 1 data was 290 used in order to maximize the size of the available dataset. Each participant served as the test exactly 291 once and predictions were evaluated using F1 scores (harmonic mean of precision and recall; Sokolova & 292 Lapalme, 2009; Lipton et al., 2014). F1 scores are often used when the proportions of two classes are 293 uneven. To determine the full scope of prediction, we repeated this analysis by increasing the 294 percentage of data labelled as a target in increments of 10% up to a maximum of 50% (i.e. median split 295 of data). To evaluate F1 scores, we generated a distribution of null F1 scores by assigning targets at 296 random and then performing the analysis described above. This procedure was carried out 10,000 times 297 and obtained F1 scores were evaluated as significant if they were equal to or surpassed the 95 th 298 percentile of the null distribution. 299
In the second analysis, we used a single linear SVM to perform cross-study classification using data from 300 the current study as the training set and data from an earlier study on CHP sensitivity as the test set 301 (external validation; Furman et al., 2018) . Prior to analysis, PAF estimates within each study were 302 normalized to z-scores. Otherwise, details of this analysis were identical to those of the within-study 303 classification analysis. 304 Figure 2 . Prolonged pain models were stable across visits. A. Average pain time courses for CHP responder (orange), CHP non-responder (blue), and high tolerance (grey) pain classifications during each prolonged pain test. Dotted lines reflect the temperature of the thermode applied to the forearm during each test. CHP responders were defined as participants with pain scores >10/100 in response to CHP, CHP non-responders were defined as participants who had pain scores <10/100 during CHP and pain scores >10/100 during PHP, and high pain tolerance individuals were defined as participants with pain scores <10/100 in response to both CHP or PHP. B. Pain ratings broken down by prolonged pain test, pain response classification, and visit. Bar graphs reflect means and error bars reflect +1 standard deviation. Scatter plots only include data from CHP responders and high tolerance individuals. Off-color data points represent statistical outliers not included in analyses and dotted lines represent the linear regression line of best fit.
To examine whether pain-free, sensorimotor PAF is reliable across Visits 1 and 2, estimates from each 306 visit were compared using a paired t-test. Bayes factor analysis was used to determine whether the null 307 hypothesis could be accepted (i.e. no change in PAF between visits). Bayes factor analysis provides a 308 method for assessing the relative evidence in favor of either the null or alternative hypothesis with a 309
Bayes factor less than .33 or greater than 3 are taken as strong evidence in favor of the null and 310 alternative hypotheses, respectively (Rouder et al., 2009 ); Bayes factor scores in-between these values 311 are considered to provide no evidence in favor of either hypothesis. As an additional test of stability, 312 PAF estimates at Visits 1 and 2 were correlated with one another. 313
The stability of prolonged pain scores was assessed using a linear mixed effects model with subjects as 314 random effects (intercept included) and Visit (Visit 1 vs Visit 2), Type (WDT vs. HPT vs. Phasic vs. CHP), 315 and the Visit X Type interaction as fixed effects. We were specifically interested in determining whether 316 scores change over time (main effect of Visit) and whether these changes were specific to individual 317 tests (Visit X Type interaction). For each prolonged pain test, Bayes factor analysis was used to 318 determine whether the null hypothesis could be accepted (i.e. no change in pain score between visits). 319
Additionally, the stability of pain scores from each test was analyzed by correlating Visit 1 and Visit 2 320 pain scores. 321
To further test of the stability of pain-free, sensorimotor PAF and prolonged pain scores, we examined 322 the correlation between pain-free, sensorimotor PAF at Visit 1 and Visit 2 pain sensitivity. To ensure that 323 results were not an artifact of our PAF estimation algorithm, we also correlated pain sensitivity scores to 324 the average, pain-free estimate of spectral power at each 0.2 Hz element within the 8-12 Hz range. 325
Finally, we tested whether pain-free, sensorimotor PAF at Visit 1 could accurately identify the least and 326 most pain sensitive individuals at Visit 2. As before, a series of leave-one-out SVMs were trained to 327 identify the least or most pain sensitive individuals and then tested on the withheld participant. 328
Performance was quantified by comparing the observed F1 score to a bootstrapped, null distribution of 329 F1 scores. 330
Results 331
From our initial cohort of 61 individuals, two individuals were removed due to abnormal pain ratings: 332 one participant fell asleep during ratings while another participant provided extremely high pain ratings 333 in the absence of any noxious stimuli indicating that they may been confused by the rating scheme. We 334 A summary of prolonged pain scores for each pain response classification is presented in Figure 2 . Both 347 PHP and CHP produced sensitization, a hallmark of prolonged pain (see Supplemental Data), and similar 348 amounts of pain in males and females (Supplemental Figure S3) . Correlations between all possible pairs 349 of tests were significant (Table 2) Figure S2E) . Furthermore, inspection of the relationship between pain sensitivity and 364 power at each frequency element within the alpha range demonstrate that these results are not an 365 artifact of our PAF calculation method: for each test, slower (8-9.5 Hz) elements were positively 366 associated with pain sensitivity while faster (10.5-12 Hz) elements were negatively associated with pain 367 sensitivity (Figure 4 Lower Panels). We found no evidence of sex effects on the relationship of PAF to 368 either PHP, CHP, or CHP rekindle (Supplemental Figure S4A) . Interestingly, the relationship between PAF 369 Given the high sensitivity of classification analyses to outliers, one participant with an extreme PAF 385 estimate was not included in either analysis (PAF = 10.65, 3.20 S.D. above the mean). In order to make 386 the classification analysis generalizable to other datasets, and to take advantage of the strong 387 correlation between prolonged pain tests, we created a composite pain sensitivity score by averaging 388 scores from all three prolonged pain tests (PHP, CHP, CHP Rekindle). This pain sensitivity score was 389 significantly correlated with PAF at both Visit 1, Spearman ρ = -.51, p < .01, and Visit 2, Spearman ρ = -390 .60, p < .01 (Supplemental Figure S7A) . This relationship remained evident when we included all 391 .03 (Supplemental Figure S7A) . 393 Support vector machines (SVM) trained and tested on the current dataset were able to identify both the 394 least and most sensitive individuals using just pain-free PAF estimates (internal validation; details found 395 in the Statistics section). Compared to a simulated null distribution of F1 scores, the least pain sensitive 396 individuals were identified at above chance levels at all labelling intervals but the 20% one ( Figure 7B ). 397
Similarly, the most sensitive individuals were identified at above chance levels at all labelling intervals 398 but the 30% one. When including all participants, regardless of classification, PAF significantly identified 399 the least sensitive individuals at all labelling intervals but only the most sensitive individuals at the 10% 400 and 50% intervals (Supplemental Figure S7B ). This latter result likely reflects that the composite pain 401 sensitivity score fails to capture the mixed sensitivity of CHP non-responders to CHP and PHP. 402
A linear SVM trained on the current dataset could identify high and low pain sensitive individuals in a 403 separate, independent study (external validation). Using a similar procedure to one used for within-404 study classification, a single linear SVM trained on data from the current study was used to predict the 405 identity of 21 participants from a previous study on CHP sensitivity . Compared to a 406 simulated null distribution of F1 scores, we found that PAF estimates identified the most pain sensitive 407 individuals at above chance levels for all labelling intervals and identified the least pain sensitive 408 individuals at above chance levels only at the two largest, 40% & 50%, intervals ( Figure 7D) . Rerunning 409 the analysis with all participants, regardless of pain response classification, included in the training set 410 yielded identical results (Supplemental Figure S7B ) 411
Sensorimotor PAF and Prolonged Pain Sensitivity Are Stable over Time 412
One possible explanation for the presence of a reliable relationship between pain-free, sensorimotor 413 PAF and prolonged pain sensitivity at Visits 1 and 2 is that both measures are themselves stable over 414 . Visit 1 pain-free, sensorimotor PAF can accurately predict the identity of the most pain sensitive individuals and a support vector machine trained on this data can identify the most pain sensitive in an independent study. A. Visit 1 pain scores from the three prolonged pain models were averaged and a relevant percentage of the sample, ranging from 10% to 50% (i.e. median split), was identified as high or low pain sensitive. Colored lines (shading = 95% confidence interval) reflect the average sensitivity for identified participants and those not classified (black lines; "Remaining"). B. A support vector machine trained on Visit 1 pain-free, sensorimotor PAF predicts the identity of high and low pain sensitive individuals from the same study at almost all labelling intervals. An F 1 score of 1 indicates perfect classifier performance and the dashed red lines reflect the 95 th % of a null distribution of F 1 scores. C. Same as in A., except pain scores were taken from an independent study on PAF and CHP . D. A support vector machine trained on Visit 1 pain-free, sensorimotor PAF predicts the identity of high pain sensitive individuals from an independent study at all labelling intervals. E. A support vector machine trained on Visit 1 painfree, sensorimotor PAF predicts the identity of Visit 2 high pain sensitive individuals. Note that pain scores for this test are not provided but are nearly identical to those present in C. What's more, the least and most pain sensitive individuals at Visit 2 could be identified using Visit 1  444 pain-free, sensorimotor PAF. Visit 2 pain sensitivity, represented as the average pain score across tests, 445
was strongly correlated to Visit 1 pain-free, sensorimotor PAF, Spearman ρ = -.66, p < .01, and remained 446 so when including all participants regardless of pain classification, Spearman ρ = -.45, p < .01 447 (Supplemental Figure S7A ). Compared to a null distribution of F1 scores, pain-free, sensorimotor PAF 448 identified the most sensitive individuals at all but the smallest labelling interval and the least sensitive 449 individuals at all but the two smallest labelling intervals (Figure 7E ). Classification failure at the smallest 450 labelling intervals was likely due to the relatively low number of targets available (sample = 30; targets = 451 3 and targets = 6 at the 10% and 20% labelling intervals, respectively). Rerunning the analysis with all 452 participants, regardless of pain response classification, again demonstrated that pain-free, sensorimotor 453 PAF could identify the most sensitive individuals at all labelling intervals but the smallest one. For the 454 least pain sensitive individuals, pain-free, sensorimotor PAF failed to yield significant predictions at any 455 labelling interval (Supplemental Figure S7B) . 456 previously shown that the speed of PAF collected in the absence of a noxious stimulus is negatively 468 related to an individual's sensitivity to future prolonged pain events (i.e. slower PAF = greater pain 469 sensitivity). This has led us to propose that pain-free PAF is a biomarker of prolonged pain sensitivity 470 and, furthermore, that chronic-pain related disturbances of PAF may reflect differences in pain 471 sensitivity that predate disease onset. 472
In the current study we examined the relationship of pain-free PAF to two models of prolonged pain, 473
Capsaicin Heat Pain (CHP) and Phasic Heat Pain (PHP), within the same group of participants at two 474 separate timepoints. From these experiments, we present two key pieces of evidence supporting the 475 hypothesis that pain-free PAF is a prolonged pain sensitivity biomarker. First, pain-free PAF shares a 476 near identical, negative relationship to CHP and PHP sensitivity, with increasingly slower PAF associated 477 with increasingly greater pain intensity during each test. While we have previously reported a 478 relationship between pain-free PAF and CHP sensitivity (Furman et al., 2018), the described relationship 479 to PHP sensitivity is entirely novel. Reproduction of this relationship across models, despite differences 480 in their length of application, the temperatures used, and the presence of a sensitizing agent, provides 481 important evidence that PAF is a marker of prolonged pain sensitivity per se and not specific portions of 482 either model. This interpretation is also supported by the replication of our earlier CHP findings despite 483 large procedural differences between the two studies (i.e. CHP preceded by a cognitive or separate pain 484 task). Preservation of the PAF-pain sensitivity relationship through the rekindling phase of the CHP 485
model provides yet another piece of evidence that PAF captures an element of the prolonged pain 486 experience that is independent of the local context (i.e. continuous vs. interrupted pain). Although the 487 association of pain-free PAF with non-thermal forms of prolonged pain was not tested in the current 488 study, similar findings in a musculoskeletal model of prolonged pain provide some assurance that pain-489 free PAF is likely to apply to a wide range of prolonged pain modalities (Furman et al., 2019) . 490 Second, the relationship between pain-free, PAF and prolonged pain sensitivity is reliable over time. well as the absence of visual and haptic feedback during rating, provides comfort that the reliability of 506 pain scores is not simply the result of participant's explicit recollection of previous pain. From a broader 507 perspective, these findings suggest the that relationship between pain-free PAF and prolonged pain is 508 not uniquely determined at each visit but is instead an association that remains consistent across time; 509 put another way, the same pain-free, PAF and the same prolonged pain sensitivity are sampled from 510 individuals at each visit. Indeed, the ability of Visit 1 pain-free PAF to predict prolonged pain sensitivity 511
at Visit 2 provides strong evidence in favor of this conclusion. Thus, these findings clearly show that 512 pain-free PAF can provide cogent information about prolonged pain sensitivity at both short (i.e. 513 minutes/hours separating PAF acquisition and pain testing) and long (weeks/months separating visits) 514 timescales. 515
Considering its apparent reliability as a pain sensitivity biomarker, as well as its ease of obtainment, 516 pain-free PAF holds real promise as a pain management and prophylaxis tool. This may be especially 517 true in cases of planned surgery, where post-operative pain sensitivity is consistently found to be an 518 important risk factor for chronic pain development (Hah et al., 2019) . For example, identification of high 519 pain sensitivity with PAF could be used to inform clinician decision making about surgical alternatives. 520
To evaluate this possible real-world application, we examined whether pain-free PAF can predict the 521 identify of high or low pain sensitive individuals. In almost all cases, a support vector machine trained on 522 pain-free PAF was able predict the identity of the most pain sensitive individuals. This held true when 523 the test data came from the current study or when it originated from an entirely separate study 524 . In contrast, identification of the least pain sensitive individuals occurred when 525 classification was applied to data from the current study but not when applied to outside data. These 526 results suggest that pain-free PAF is particularly well suited for identifying high pain sensitive individuals. 527
Importantly, Visit 1 pain-free PAF could be used to predict high pain sensitivity at Visit 2 suggesting that 528 pain sensitivity prediction remains relevant across clinically relevant periods of time. Prospective 529 collection of pain-free PAF at routine check-ups may therefore prove an effective strategy for ensuring 530 information about an individual's pain sensitivity is available to clinicians in cases of unplanned surgical 531 intervention. 532
Despite the promise of the current findings, some potential limitations must be acknowledged. First, a 533 subset of individuals demonstrating insensitivity to CHP were not included in the main set of analyses. 534
Although a wide range of factors can render an individual less sensitive to capsaicin, at least some cases 535 appear to be determined by physiological factors, like genetic polymorphisms (Campbell et al., 2009) averaging pain scores across tests revealed that, even when including all participants, this broader 547 description of pain sensitivity was well described by pain-free PAF. As a result, we feel confident that 548 pain-free PAF's relationship to pain sensitivity holds broadly across individuals. 549 Additionally, the current study is unable to provide concrete information about PAF's source or identity. 550 For the sole purpose of remaining consistent with our earlier methods, we chose to explicitly focus on 551 PAF recorded from sensorimotor channels. As we have noted previously (Furman et al., 2019 ), PAF's 552 relationship to pain sensitivity is not restricted to sensorimotor channels and instead appears to 553 encompass nearly every scalp channel. This continued to hold true in the current study even when 554 possible volume conduction effects were controlled with a Laplacian transform. Although considered a 555 limitation here, the widespread nature of PAF's relationship to pain sensitivity may provide an 556 important clue to its identity. In line with findings that the alpha rhythm travels across the cortex in 557 "waves" (Zhang et Some readers may also be concerned with the limited, 9-11 Hz frequency range that was used to 568 calculate PAF. Alpha activity is not limited to 9-11 Hz range and has even been suggested to extend 569 beyond the canonical 8-12 Hz range (Haegens et al., 2014) . One advantage of the restricted calculation 570 range we employed is that it most effectively negates the impact of the 1/f aperiodic signal on PAF 571 estimation positive relationship to pain sensitivity whereas elements above 10 Hz were negatively associated with 579
pain. This finding reinforces that where power is expressed within the alpha range is relevant to pain 580 sensitivity and, furthermore, suggests that different elements of the alpha range represent distinct 581 processes (e.g. Klimesch et al., 1998) . 582
In summary, our results clearly demonstrate that pain-free PAF is a reliable predictor of prolonged pain 583 sensitivity. In addition to demonstrating that pain-free PAF is related to multiple models of prolonged 584 pain, we provide compelling evidence that this relationship is stable over both immediate, i.e. 585 minutes/hours, and more extended, i.e. weeks/months, periods of time. Furthermore, we demonstrate 586 that pain-free PAF can be used to accurately identify high pain sensitive individuals in multiple datasets. 587
These findings now firmly position pain-free PAF as a biomarker of pain sensitivity with untapped 588 potential in clinical settings. 589 multi-collinearity, independent variables and moderators were mean centered. In our moderation 799 analyses, a significant interaction of sex and PAF would indicate that the relationship between PAF and 800 pain sensitivity is different for the two sexes. The PAF x Sex interaction failed to reach significance for 801 PHP scores at either V1, t = -.16, p = .87, or V2, t = .74, p = .47 or for CHP scores at either V1, t = -.01, p = 802 .99, or V2, t < .01, p > .99. For CHP rekindle, the PAF x Sex interaction was not significant at either V1, t = 803 -1.01, p = .32, or V2, t = -.98, p = .34. According to our moderation analyses we can conclude that the 804 PAF-pain sensitivity relationship is not different for the two sexes. 805
The PAF-Pain Sensitivity Relationship is Evident Across the Entire Scalp 806
Previously unpublished findings from our lab have suggested that the PAF-pain sensitivity relationship is 807 not privileged to channels that putatively sample the sensorimotor cortex. To determine whether similar 808 conclusions can be drawn from the current dataset, we first calculated pain-free PAF separately at each 809 of the 63 EEG channels. Next, we correlated PAF estimates from each channel with scores on each 810 sensory test to yield a total of 63 correlation values for each prolonged pain test. As can be seen in 811
Supplementary Figure S5 , the distribution of sensor correlations largely recapitulated what we found 812 when we focused only on our sensorimotor ROI. Specifically, we found that correlations between PAF 813 and PHP, CHP and CHP rekindle were moderately large and in the negative direction. Accounting for the 814 possible effects of volume conduction with a surface Laplacian transformation did not change these 815 conclusions (Supplemental Figure S6 ). 816 817
Classification of Pain Sensitivity Using PAF: Results When Including All Participants 818 819
Correlations between average pain sensitivity to all tests and pain-free, sensorimotor PAF are presented 820 in Figure S7 . Whether considering only CHP responders and high tolerance individuals (left panels), or all 821 participants (right panels), pain-free, sensorimotor PAF was significantly related to this composite 822 measure of pain sensitivity. 823 824
A series of within-study linear support vector machines trained on all available data from the current 825 study identified the least sensitive individuals at above chance levels for all labelling intervals. When 826 trying to identify the most sensitive individuals, the support vector machine was only able to do so at 827 the smallest (10%) and largest (50%; i.e. median-split) labelling intervals. This latter result likely reflects 828 that our composite score is an inaccurate description of the mixed sensitivity of CHP non-responders 829 (i.e. insensitive to CHP but sensitive to PHP). 830 Figure S5 . Relationship between pain-free PAF and prolonged pain sensitivity is observable across the entire EEG montage. For each prolonged pain test, and each of the 63 individual EEG sensors, the Spearman correlation between channel-level PAF and pain scores was computed to yield a total of 63 correlations coefficients for each test. Results for Visits 1 and 2 are presented either on the scalp (A) or as distributions (B). Figure S6 . Relationship between pain-free PAF and prolonged pain sensitivity is observable across the entire EEG montage even after accounting for possible effects of voltage conduction. Prior to estimation of spectral power, a surface Laplacian transformation was applied to the preprocessed EEG data. For each prolonged pain test, and each of the 63 individual EEG channels, the Spearman correlation between channel PAF and pain scores was calculated to yield a total of 63 correlations coefficients for each test. Results for Visits 1 and 2 are presented either on the scalp (A) or as distributions (B). 
